Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9018)
All Articles published online
|
Publishing Process of This Article
|
May 18, 2015 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Colagrande S, Regini F, Taliani GG, Nardi C, Inghilesi AL. Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-up. World J Hepatol 2015; 7(8): 1041-1053 [PMID: PMC4450181 DOI: 10.4254/wjh.v7.i8.1041] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i8/1041.htm |
| Number | Citing Articles |
| 1 |
Luigi Mele, Vitale del Vecchio, Davide Liccardo, Claudia Prisco, Melanie Schwerdtfeger, Nirmal Robinson, Vincenzo Desiderio, Virginia Tirino, Gianpaolo Papaccio, Marcella La Noce. The role of autophagy in resistance to targeted therapies. Cancer Treatment Reviews 2020; 88: 102043 doi: 10.1016/j.ctrv.2020.102043
|
| 2 |
Qingfang Li, Zhihui Li, Ting Luo, Huashan Shi. Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy. Molecular Biomedicine 2022; 3(1) doi: 10.1186/s43556-022-00110-2
|
| 3 |
Yongxiang Yi, Jianbo Han, Yuan Fang, Dongxiao Liu, Zuoyou Wu, Lili Wang, Liang Zhao, Qiang Wei. Sorafenib and a novel immune therapy in lung metastasis from hepatocellular carcinoma following hepatectomy: A case report. Molecular and Clinical Oncology 2016; 5(2): 337 doi: 10.3892/mco.2016.925
|
| 4 |
Ziyue Wang, Jinren Liu, Zihao Zhou, Junli Yu, Liguo Hao, Shunxin Hu, Zhongzhong Lu, Li Wang, Yan Ding. Cell Membrane-Coated Hollow Manganese Dioxide Drug Delivery Nanosystem for Targeted Liver Cancer Diagnosis and Treatment. ACS Applied Nano Materials 2024; 7(16): 18262 doi: 10.1021/acsanm.3c03592
|
| 5 |
Sascha Kaufmann, Wolfgang M Thaiss, Maximilian Schulze, Michael Bitzer, Ulrich Lauer, Konstantin Nikolaou, Marius Horger. Prognostic value of perfusion CT in hepatocellular carcinoma treatment with sorafenib: comparison with mRECIST in longitudinal follow-up. Acta Radiologica 2018; 59(7): 765 doi: 10.1177/0284185117732805
|
| 6 |
Weiwei Tang, Ziyi Chen, Wenling Zhang, Ye Cheng, Betty Zhang, Fan Wu, Qian Wang, Shouju Wang, Dawei Rong, F. P. Reiter, E. N. De Toni, Xuehao Wang. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-0187-x
|
| 7 |
Kasra Mokhtarpour, Milad Akbarzadehmoallemkolaei, Nima Rezaei. . Interdisciplinary Cancer Research 2024; doi: 10.1007/16833_2024_419
|
| 8 |
S. Colagrande, L. Calistri, C. Campani, G. Dragoni, C. Lorini, C. Nardi, A. Castellani, F. Marra. CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib. European Radiology 2021; 31(3): 1608 doi: 10.1007/s00330-020-07171-3
|
| 9 |
Sancharan Acharya, Chinnasamy Thirunavukkarasu. Gut Microbiome and Cancer: From Cancer Development to Therapeutics with a Special Focus on Hepatocellular Carcinoma. Frontiers in Bioscience-Landmark 2024; 29(2) doi: 10.31083/j.fbl2902067
|
| 10 |
K. Okrah, S. Tarighat, B. Liu, H. Koeppen, M. C. Wagle, G. Cheng, C. Sun, A. Dey, M. T. Chang, T. Sumiyoshi, Z. Mounir, C. Cummings, G. Hampton, L. Amler, J. Fridlyand, P. S. Hegde, S. J. Turley, M. R. Lackner, S. M. Huang. Transcriptomic analysis of hepatocellular carcinoma reveals molecular features of disease progression and tumor immune biology. npj Precision Oncology 2018; 2(1) doi: 10.1038/s41698-018-0068-8
|
| 11 |
Fabio Melchiorre, Francesca Patella, Lorenzo Pescatori, Filippo Pesapane, Enrico Fumarola, Pierpaolo Biondetti, Pietro Brambillasca, Cristian Monaco, Anna Maria Ierardi, Giuseppe Franceschelli, Gianpaolo Carrafiello. DEB-TACE: A Standard Review. Future Oncology 2018; 14(28): 2969 doi: 10.2217/fon-2018-0136
|
| 12 |
Daniela Coelho dos Santos, Jamal Rafique, Sumbal Saba, Gabriela M. Almeida, Tâmila Siminski, Cynthia Pádua, Danilo W. Filho, Ariane Zamoner, Antonio L. Braga, Rozangela C. Pedrosa, Fabiana Ourique. Apoptosis oxidative damage‐mediated and antiproliferative effect of selenylated imidazo[1,2‐a]pyridines on hepatocellular carcinoma HepG2 cells and in vivo. Journal of Biochemical and Molecular Toxicology 2021; 35(3) doi: 10.1002/jbt.22663
|
| 13 |
Stefan F. Thieme, Janis L. Vahldiek, Katja Tummler, Franz Poch, Ole Gemeinhardt, Bernhard Hiebl, Kai S. Lehmann, B. Hamm, Stefan M. Niehues, L. Prantl, E.M. Jung, F. Jung. Value or waste: Perfusion imaging following radiofrequency ablation – early experience. Clinical Hemorheology and Microcirculation 2015; 61(2): 323 doi: 10.3233/CH-152000
|
| 14 |
Lekshmi R. Nath, Mundanattu Swetha, Vinod Vijayakurup, Arun Kumar Thangarasu, Nair Hariprasad Haritha, Anwar Shabna, Sreekumar U. Aiswarya, Tennyson P. Rayginia, C. K. Keerthana, Kalishwaralal Kalimuthu, Sankar Sundaram, Ravi Shankar Lankalapalli, Sreekumar Pillai, Rheal Towner, Noah Isakov, Ruby John Anto. Blockade of Uttroside B-Induced Autophagic Pro-Survival Signals Augments Its Chemotherapeutic Efficacy Against Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.812598
|
| 15 |
Lekshmi R Nath, Mundanattu Swetha, Vinod Vijayakurup, Arun Kumar Thangarasu, Nair Haiprasad Haritha, Sreekumar U. Aiswarya, Tennyson P. Rayginia, C.K. Keerthana, Kalishwaralal Kalimuthu, Sankar Sundaram, Ravi Shankar Lankalapalli, Sreekumar Pillai, Rheal Towner, Noah Isakov, Ruby John Anto. Blockade of Uttroside B-Induced Autophagic Pro-Survival Signals Augments its Chemotherapeutic Efficacy Against Hepatocellular Carcinoma. SSRN Electronic Journal 2021; doi: 10.2139/ssrn.3942642
|
| 16 |
Guoqing Ouyang, Guangdong Pan, Honglai Xu, Yongrong Wu, Zhen Liu, Wuhang Lu, Bin Yi, Xiang Chen. Sorafenib Plus Hepatic Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 2020; 54(8): 675 doi: 10.1097/MCG.0000000000001384
|
| 17 |
Wenting Wang, Tao Wang, Hongyun Lin, Desheng Liu, Peng Yu, Jing Zhang. Ropivacaine combined with sorafenib attenuates hepatocellular carcinoma cell proliferation and metastasis by inhibiting the miR‐224/HOXD10 axis. Environmental Toxicology 2024; 39(4): 2429 doi: 10.1002/tox.24111
|
| 18 |
Jinrui Wei, Xuqi Zhao, Fuli Long, Kunpeng Tian, Lichuan Wu. Lianhua Qingwen exerts anti-liver cancer effects and synergistic efficacy with sorafenib through PI3K/AKT pathway: Integrating network pharmacology, molecular docking, and experimental validation. Gene 2024; 912: 148383 doi: 10.1016/j.gene.2024.148383
|
| 19 |
Chao-Nan Qian, Min-Han Tan, Jun-Ping Yang, Yun Cao. Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation. Chinese Journal of Cancer 2016; 35(1) doi: 10.1186/s40880-015-0070-2
|
| 20 |
Haidong Zhang, Xuanlong Du, Hui Dong, Wenjing Xu, Pengcheng Zhou, Shiwei Liu, Xin Qing, Yu Zhang, Meng Yang, Yewei Zhang. Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02424-5
|
| 21 |
Stefano Colagrande, Andrea Magnini, Lorenzo Cinci. Editorial for “Clinical‐Radiologic Morphology‐Radiomics Model on Gadobenate Dimeglumine‐Enhanced MRI for Identification of Highly Aggressive Hepatocellular Carcinoma: Temporal Validation and Multiscanner Validation”. Journal of Magnetic Resonance Imaging 2024; 60(6): 2655 doi: 10.1002/jmri.29328
|
| 22 |
Hui‐Huang Lai, Chih‐Wei Li, Chih‐Chen Hong, Hung‐Yu Sun, Ching‐Feng Chiu, Da‐Liang Ou, Pai‐Sheng Chen. TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma. Molecular Oncology 2019; 13(4): 928 doi: 10.1002/1878-0261.12449
|
| 23 |
Xiaomin Ma, Yumin Qiu, Lihui Zhu, Yunxue Zhao, Yueke Lin, Dapeng Ma, Zhenzhi Qin, Caiyu Sun, Xuecheng Shen, Tao Li, Lihui Han. NOD1 inhibits proliferation and enhances response to chemotherapy via suppressing SRC-MAPK pathway in hepatocellular carcinoma. Journal of Molecular Medicine 2020; 98(2): 221 doi: 10.1007/s00109-019-01868-9
|
| 24 |
Cheng Jin, You-Yi Liu, Bo-Shi Wang. Liver Cancer - Genesis, Progression and Metastasis. 2023; doi: 10.5772/intechopen.108559
|
| 25 |
Tarek El-Sewedy, Afrah Fatthi Salama, Amro E. Mohamed, Nashwa M. Elbaioumy, Ali H. El-Far, Aisha Nawaf Albalawi, Alaa Elmetwalli. Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death. BMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-023-04142-1
|
| 26 |
Chaobo Hu, Weiping Li, Feng Tian, Kai Jiang, Xiaoting Liu, Jin Cen, Qiang He, Zhixin Qiu, Yvonne Kienast, Zhong Wang, Haibin Zhang, Yuan Ji, Junhao Hu, Lijian Hui. Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma. Journal of Hepatology 2018; 68(3): 465 doi: 10.1016/j.jhep.2017.10.028
|
| 27 |
Fan Feng, Lianhong Pan, Jiaqin Wu, Mingying Liu, Long He, Li Yang, Wei Zhou. Schisantherin A inhibits cell proliferation by regulating glucose metabolism pathway in hepatocellular carcinoma. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1019486
|
| 28 |
Ruyuan Liu, Huanyu Cui, Di Li, Xuefeng Guo, Zhengbao Zhang, Shengkui Tan, Xiaonian Zhu. Roles and Mechanisms of Ferroptosis in Sorafenib Resistance for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2024; : 2493 doi: 10.2147/JHC.S500084
|
| 29 |
Shuohui Yang, Jiang Lin, Fang Lu, Zhihong Han, Caixia Fu, Hongchen Gu. Use of Ultrasmall Superparamagnetic Iron Oxide Enhanced Susceptibility Weighted Imaging and Mean Vessel Density Imaging to Monitor Antiangiogenic Effects of Sorafenib on Experimental Hepatocellular Carcinoma. Contrast Media & Molecular Imaging 2017; 2017: 1 doi: 10.1155/2017/9265098
|
| 30 |
Ester Jo, Kush Savsani, Anjelica Alfonso, Andrew Park, Seung Duk Lee, Devanand Sakar, Nathaniel Kinsey, Yuzuru Sambommatsu, Daisuke Imaid, Aamir Khan, Amit Sharma, Muhammad Saeed, Vinay Kumaran, Adrian Cotterell, Marlon Levy, David Bruno. Photodynamic effect of indocyanine green and its application to hepatocellular carcinoma treatment. Journal of Cancer Metastasis and Treatment 2024; doi: 10.20517/2394-4722.2024.18
|
| 31 |
Mehmet Tonkaz, Omer Fatih Nas, Duygu Erkal Tonkaz, Mehmet Fatih Inecikli, Gokhan Ongen, Guven Ozkaya. Efficacy of transarterial chemoembolization treatment with 30–60-μm microspheres in patients with hepatocellular carcinoma. Die Radiologie 2024; 64(S1): 131 doi: 10.1007/s00117-024-01351-8
|
| 32 |
Shiyu Qi, Shoulong Deng, Zhengxing Lian, Kun Yu. Novel Drugs with High Efficacy against Tumor Angiogenesis. International Journal of Molecular Sciences 2022; 23(13): 6934 doi: 10.3390/ijms23136934
|
| 33 |
Kwon Yong Tak, Hee Chul Nam, Jong Young Choi, Seung Kew Yoon, Chang Wook Kim, Hee Yeon Kim, Sung Won Lee, Hae Lim Lee, U Im Chang, Do Seon Song, Jin Mo Yang, Jung Hyun Kwon, Sun Hong Yoo, Pil Soo Sung, Sang Wook Choi, Myeong Jun Song, Seok Hwan Kim, Jeong Won Jang. Effectiveness of sorafenib dose modifications on treatment outcome of hepatocellular carcinoma: Analysis in real‐life settings. International Journal of Cancer 2020; 147(7): 1970 doi: 10.1002/ijc.32964
|
| 34 |
Zhi-Hai Wu, Hai-Feng Zhang, Jun-Yan Li, Yi-Rui Diao, Man-Jing Huang, Dong-Yang Gao, Chang-Hao Liang, Zhi-Qiang Luo. Effectiveness and safety of brucea javanica oil assisted TACE versus TACE in the treatment of liver cancer: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1337179
|
| 35 |
Shuo-hui Yang, Jiang Lin, Fang Lu, Zhi-hong Han, Cai-xia Fu, Peng Lv, Hao Liu, Dong-mei Gao. Evaluation of antiangiogenic and antiproliferative effects of sorafenib by sequential histology and intravoxel incoherent motion diffusion-weighted imaging in an orthotopic hepatocellular carcinoma xenograft model. Journal of Magnetic Resonance Imaging 2017; 45(1): 270 doi: 10.1002/jmri.25344
|
| 36 |
Chunye Zhang, Ming Yang, Aaron C. Ericsson. The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.524205
|
| 37 |
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?. World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
|
| 38 |
Haoyang Chen, Huihui Liu, Xiaowei Zhang, Suhua Wang, Chunxia Liu, Ke An, Ruijuan Liu, Xin Tian. Diversified applications of hepatocellular carcinoma medications: molecular-targeted, immunotherapeutic, and combined approaches. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1422033
|
| 39 |
Cassia Regina Guedes Leal, Cristiane Magalhães, Daniel Barbosa, Diogo Aquino, Bernardo Carvalho, Elizabeth Balbi, Lucio Pacheco, Renata Perez, Paulo de Tarso Pinto, Sérgio Setubal. Survival and tolerance to sorafenib in Child-Pugh B patients with hepatocellular carcinoma: a prospective study. Investigational New Drugs 2018; 36(5): 911 doi: 10.1007/s10637-018-0621-x
|
| 40 |
Zoe Leung, Frankie Chi Fat Ko, Sze Keong Tey, Ernest Man Lok Kwong, Xiaowen Mao, Bonnie Hei Man Liu, Angel Po Yee Ma, Yi Man Eva Fung, Chi-Ming Che, Danny Ka Ho Wong, Ching Lung Lai, Irene Oi-Lin Ng, Judy Wai Ping Yam. Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1402-x
|
| 41 |
Marta Campos, Isabel Candelária, Nickolas Papanikolaou, Adélia Simão, Carlos Ferreira, Georgios C. Manikis, Filipe Caseiro-Alves. Perfusion Magnetic Resonance as a Biomarker for Sorafenib-Treated Advanced Hepatocellular Carcinoma: A Pilot Study. GE - Portuguese Journal of Gastroenterology 2019; 26(4): 260 doi: 10.1159/000493351
|
| 42 |
Qian-Han Xiao, Ze-Zhi Li, Li Ren, Shu-Yao Wang, Xiao-Qiang Li, Hong-Xin Bai, Rui-Zhi Qiao, Na Tang, Wen-Juan Liu, Jing-Mei Wang, Guang-Yuan Ma, Dian-Chao Dong, Ke-Han Wu, Wei Cao. α-Glucan derivatives as selective blockers of aldolase A: Computer-aided structure optimization and the effects on HCC. Carbohydrate Polymers 2024; 325: 121566 doi: 10.1016/j.carbpol.2023.121566
|